Abiomed Stock Price and Value Analysis

Should you buy Abiomed stock? (NasdaqGS:ABMD). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the ABMD Numbers

ABMD Price
(Abiomed stock price per share)
[?] ABMD Fair Price
(based on intrinsic value)
[?] ABMD Safety Price (based on a variable margin of safety) $18.86
[?] PE Ratio versus Sector 279% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Devices stocks
[?] Cash Yield 0.24%
[?] Free Cash Flow Jitter 73%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,966,892 shares shorted. With 44,559,849 shares available for purchase and an average trading volume over the past 10 trading days of 1,367,710, it would take at least 1.438 days for all of the short holders to cover their shorts.

Is Abiomed Stock on Sale?

We believe that Abiomed may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Abiomed looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy ABMD Stock?

Does Abiomed have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.